Source: Clinics. Unidade: FMRP
Subjects: NEOPLASIAS, MAMA, QUIMIOTERAPIA, PROGNÓSTICO (FATORES)
ABNT
TIEZZI, Daniel Guimarães; CLAGNAN, Willian Simões; MANDARANO, Larissa Raquel Mouro; et al. Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer. Clinics, São Paulo, v. 68, n. 5, p. 592-598, 2013. Disponível em: < http://dx.doi.org/10.6061/clinics/2013(05)03 > DOI: 10.6061/clinics/2013(05)03.APA
Tiezzi, D. G., Clagnan, W. S., Mandarano, L. R. M., Sousa, C. B. de, Marana, H. R. C., Tiezzi, M. G., & Andrade, J. M. de. (2013). Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer. Clinics, 68( 5), 592-598. doi:10.6061/clinics/2013(05)03NLM
Tiezzi DG, Clagnan WS, Mandarano LRM, Sousa CB de, Marana HRC, Tiezzi MG, Andrade JM de. Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer [Internet]. Clinics. 2013 ; 68( 5): 592-598.Available from: http://dx.doi.org/10.6061/clinics/2013(05)03Vancouver
Tiezzi DG, Clagnan WS, Mandarano LRM, Sousa CB de, Marana HRC, Tiezzi MG, Andrade JM de. Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer [Internet]. Clinics. 2013 ; 68( 5): 592-598.Available from: http://dx.doi.org/10.6061/clinics/2013(05)03